Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
Danielle BancroftBest Practice Software
Melva PetersJenaker Consultingx
Jean Duteau (Chair)Duteau Designx
John HatemIndependent Consultantx
Scott Robertson Kaiser Permanentex
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCPx
Isaac VetterEpic
Joe QuinnSmile CDRx
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDPx
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealandx
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborativex
Stephen ChuADHAx
Tim McNeilSurescriptsx
Kim RobertsPharmacy HIT Collaborative
Kent BulzaWell Health
Phung Matthews3M
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

2022-06-13 Agenda/Meeting Notes - accepted by General Consent

Project Review

Project Proposals

Project Scope Statements

External Meeting Review

Catalog Updates (John Hatem)

  • - no recent meetings
    • Catalog project open to meeting - ask us to go to their meeting on Fridays at 12 noon Eastern
      • John will confirm a date - will likely be in August

Workflow Update (John Hatem) 

- meeting today discussed BPMN.  No pharmacy specific workflow issues

Healthcare Product Update (John Hatem)

  • - Trackers and updates.  No pharmacy specific issues. 

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

  • - cRML meeting cancelled.  Project leadership still transitioning to new company.

NCPDP Updates (NCPDP Members)

WG18 Patient Consent TG:

    • Addition of Consent to HL7 Specialty Rx FHIR IG  will be balloted as a new version of the Specialty Medication Enrollment Guide in September
    • Connectathon
      • New application was created that illustrates the content of the implementation guide and it demonstrates how the application will use the standard that is defined to request the consent and provide the appropriate consent form to the clinic.
      • The clinic can see the request and work it in to the workflow process, update the request, complete the request, and view it.
      • Focus is on the exchange process while the patient is at the clinic
      • In this process there is still exchange of PDFs
    • Link for Consent Simulator - Patient Requester View
      • From this page it is possible to view the form, submit request and view the status of consent
    • There will be a discussion with the HL7 Community Based Care and Privacy WG in the next couple of weeks to review the plan and what was learned at the Connectathon
      • They will be co-sponsoring the effort to add consent to the guide and take this to ballot
    • NCPDP Meetings are scheduled for June 23, July 7, and July 21st at 11:00 am US Central Time
    • NIB - Melva to create draft and send to Frank to complete
  • - NIB needed
    • Frank working on content - must have content for review for next weeks meeting
    • there are some things in the IG that could be corrected - examples could be corrected
      • create Jira issues as technical corrections that can be included
      • NIB doesn't have to call them out, but they should be included in the IG version history

MC Consumer and Provider RTPB Standards Monitoring Sub-Task Group

    • HL7® FHIR® Jira tickets status for RTPB Standard vs Consumer RTPB Check Imp Guide gaps have been submitted. Waiting on CARIN Alliance. The sub-TG continues to monitor state legislation and regulations.
    • NCPDP Meetings are scheduled for June 27, July 11 and July 25 at 12:00 pm US Central Time
  • no update

All NCPDP Meeting information can be obtained at


PDex Formulary (Corey)

  • - no update

Pharmacist Consult Note (Scott)

    • NCPDP TG decided to continue with the HL7/NCPDP guidance document and possibly tackle an IG at a later date.
    • NCPDP meetings are scheduled for June 16, June 30, and July 14 at 10:00 am US Central Time
    • NIB for approval - reviewed and updated
    • Motion - Scott and Margaret to approve NIB - 11-0-0 Carried
    • NIB submitted
    • working on content - working on additional use cases

FHIR (Group)

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

  • Question about FHIR-35893 - agreed to add DeviceDefinition to performer and remove Device, but we added a new attribute of Device to MedicationRequest with a reference to DeviceDefinition as part of FHIR-37401 - reviewed and agreed that we need to apply this change
    • Jean Duteau to create a new JIRA issue will be added to clarify definitions for both MedRequest and MedAdmin FHIR-37631 - Getting issue details... STATUS
      • Stephen to add more information in to JIRA issue Stephen Chu 

Any Other Business

Question from Pharmacy List from Tom Oniki (from 3M)

  1. Are there any sources that have real, de-identified examples of valid FHIR MedicationAdministration resources?
    1. Our examples in the FHIR resources were created from scratch based on real use cases and not de-identified examples (e.g. not from an EHR system)
  2. Oxygen
    1. Do people exchange (in v2 or FHIR) oxygen therapy information (e.g., the patient was receiving 6L/min oxygen, or the patient was on a Venturi mask delivering 40% Oxygen) as medication administrations? (I've seen in the v2 spec for RXO, "It can be used for . . .other non-pharmacy treatments, e.g., respiratory therapy, oxygen, and metabolites." And I've seen an RxNorm code for "40% Oxygen.")
      1. we are aware of one system that used ServiceRequest for the request and Procedure for the administration.
      2. we believe that MedRequest and MedAdmin could be used (NDC codes or RxNorm code) for this
    2. Or do people use observations? (e.g., flow rate = 6L/min or FiO2=40)
    3. Is the answer "it depends"? If so, how does one make the decision?
      1. Using MedRequest allows you to specify flow rate in the dosage
      2. We believe you should use MedRequest and MedAdmin
      3. We don't have any examples, but if you have examples and want to provide them, we can update the Pharmacy resources

Meeting on July 4th

  • Will be cancelled - Melva Peters to cancel meeting in Conference Call Center

Next meeting: